Get the tools used by (smart)
2
investors.
Get Started
Search
SP500 
0.6%
DOW 
0.6%
FTSE 100 
-0.3%
NIKKEI 
-3.1%
OIL 
0.9%
GOLD 
0.2%
Sign In
Watchlists
Ideas
Screener
Data Explorer
Charts
Saved Work
Collapse
Relay Therapeutics Inc
NASDAQGM:RLAY
United States / Healthcare / Biotechnology
Currency
$
+ Add Watchlist
Overview
Dividends
Earnings
Models
Financials
Compare
Health
Charts
Relay Therapeutics, Inc. (RLAY)
Ovid Therapeutics Inc. (OVID)
Syros Pharmaceuticals, Inc. (SYRS)
Caribou Biosciences, Inc. (CRBU)
Regen BioPharma, Inc. (RGBP)
Vaxart, Inc. (VXRT)
AVITA Medical, Inc. (RCEL)
Performance vs Valuation Benchmarks
-125.0%
75.0%
376.0%
-4.0x
-3.0x
-2.0x
-1.0x
RLAY
OVID
SYRS
CRBU
RGBP
VXRT
RCEL
X
Axis
Revenue Growth
Y
Axis
P/E Ratio
Size
Market Cap
Price Performance History
1 Year
3 Years
5 Years
Assets:
0.24x (-76.39%)
S&P 500 (SPY):
1.09x (8.89%)
Assets
S&P 500 (SPY)
Summary Table
Market View
Risk
Returns
Efficiency
Projections
Health
Add View
Name
Price, Current
Fair Value (FINBOX)
Fair Value Label (FINBOX)
Fair Value (Analyst Targets)
Fair Value Label (Analyst Targets)
Label
Market Cap
Dividend Per Share
Dividend Yield
Relative Strength Index (14d)
P/E Ratio
Price / Book
Price / LTM Sales
Enterprise Value (EV)
Total Debt / Total Capital
Float Shares / Outstanding
CRBU
Caribou Biosciences, Inc.
$0.86
2.4%
$1.29
50.3% Upside
Undervalued
$10
1,061.4% Upside
Bargain
weak
80.077 M
-
0.0%
33.26
-0.5x
0.3x
8.0x
-142.8 M
25.3%
90.3%
OVID
Ovid Therapeutics Inc.
$0.34
9.7%
$0.48
42.4% Upside
Undervalued
$3
782.4% Upside
Bargain
weak
24.166 M
-
0.0%
28.71
-0.9x
0.4x
42.7x
-14.154 M
40.1%
71.0%
RCEL
AVITA Medical, Inc.
$7.81
4.4%
$10.59
35.5% Upside
Undervalued
$16.81
115.2% Upside
Bargain
fair
205.9 M
-
0.0%
32.63
-3.3x
45.8x
3.2x
216 M
17.6%
98.1%
RGBP
Regen BioPharma, Inc.
$0.057
20.0%
$0.054
-5.8% Downside
Fair
-
Unknown
weak
602.888 K
-
0.0%
44.92
-0.7x
-0.1x
2.5x
1.38 M
60.1%
100.0%
RLAY
Relay Therapeutics, Inc.
$2.49
0.8%
$3.42
37.2% Upside
Undervalued
$18
622.9% Upside
Bargain
weak
422.1 M
-
0.0%
29.48
-1.2x
0.5x
42.2x
-310.7 M
10.4%
70.6%
SYRS
Syros Pharmaceuticals, Inc.
$0.025
3.1%
$0.039
57.5% Upside
Undervalued
$1
3,900.0% Upside
Bargain
weak
670.811 K
-
0.0%
29.16
0.0x
-0.1x
1.7x
2.622 M
99.0%
89.2%
VXRT
Vaxart, Inc.
$0.35
5.4%
$0.51
44.7% Upside
Undervalued
$4
1,042.9% Upside
Bargain
fair
79.782 M
-
0.0%
21.15
-1.1x
1.3x
2.6x
46.524 M
21.5%
94.2%
1
Rows
10
10
30
50
100
All rights reserved.
Terms Of Use
RCEL